Larissa Nekhlyudov
Overview
Explore the profile of Larissa Nekhlyudov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
190
Citations
4437
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hertz D, Tanay M, Tofthagen C, Rossi E, Bernasconi D, Sheffield K, et al.
Support Care Cancer
. 2025 Feb;
33(2):142.
PMID: 39899120
Purpose: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating toxicity of many drugs used in cancer treatment. There are numerous available strategies for preventing or treating CIPN, but few are guideline-recommended,...
2.
Lai-Kwon J, Heynemann S, Hart N, Chan R, Smith T, Smith A, et al.
Acta Oncol
. 2024 Dec;
63:939-942.
PMID: 39651930
No abstract available.
3.
Dixit N, Avilez L, Honcharov V, Knopf K, Bedi T, Nekhlyudov L, et al.
J Cancer Surviv
. 2024 Nov;
PMID: 39557760
Background: More than 60% of cancer survivors report unmet physical, psychosocial, and informational needs. The care of cancer survivors includes surveillance, health maintenance monitoring, referral for long-term adverse effects of...
4.
Nekhlyudov L, Levit L, Ganz P
J Clin Oncol
. 2024 Oct;
42(36):4342-4351.
PMID: 39356979
In 2012, the National Academies of Sciences, Engineering, and Medicine convened a committee charged with addressing the quality of cancer care in the United States and providing recommendations to policymakers...
5.
Nekhlyudov L, Stout N
JAMA Netw Open
. 2024 Jul;
7(7):e2418686.
PMID: 38958982
No abstract available.
6.
Signorelli C, Hoeg B, Asuzu C, Centeno I, Estape T, Fisher P, et al.
JCO Glob Oncol
. 2024 May;
10:e2300418.
PMID: 38781550
Purpose: The number of cancer survivors living with and beyond cancer treatment is rising globally. It is fundamental to understand the extent and type of psychosocial care services offered worldwide....
7.
Bradford N, Chan R, Skrabal Ross X, Thamm C, Sharwood E, Pole J, et al.
J Cancer Surviv
. 2024 May;
PMID: 38722536
Purpose: This study aimed to systematically map elements of care and respective outcomes described in the literature for different models of post-treatment care for survivors of childhood cancer. Methods: MEDLINE,...
8.
Gupta N, Kim D, Conomikes A, Murad F, Nekhlyudov L, Faling D, et al.
Dermatol Surg
. 2024 May;
50(7):611-615.
PMID: 38700380
Background: Risk stratification can identify individuals in primary care settings who are at increased risk of developing melanoma. Objective: Converting and implementing a validated risk stratification tool as a patient...
9.
Hart N, Nekhlyudov L, Smith T, Yee J, Fitch M, Crawford G, et al.
JCO Oncol Pract
. 2024 Apr;
20(9):1160-1172.
PMID: 38684036
Purpose: People with advanced or metastatic cancer and their caregivers may have different care goals and face unique challenges compared with those with early-stage disease or those nearing the end...
10.
Hart N, Nekhlyudov L, Smith T, Yee J, Fitch M, Crawford G, et al.
Support Care Cancer
. 2024 Apr;
32(5):313.
PMID: 38679639
Purpose: People with advanced or metastatic cancer and their caregivers may have different care goals and face unique challenges compared to those with early-stage disease or those nearing the end-of-life....